.After declaring a period 3 launch based upon beneficial midstage end results, iTeos and GSK are act...
.The FDA should be much more available as well as collaborative to discharge a rise in approvals of ...
.It's an unusually busy Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bicara Rehabs al...
.Atea Pharmaceuticals' antiviral has actually fallen short yet another COVID-19 trial, but the biote...
.Neurocrine Biosciences' mental illness plan pivot has fallen short. The biotech was actually not ab...
.Sanofi has actually created a late access to the radioligand celebration, spending one hundred mill...
.After F2G's very first try to obtain a new class of antifungal to market was actually thwarted by t...
.Moderna has promised to cut R&D costs through $1.1 billion through 2027. The choice to shrink th...
.Simply 4 months after Sanofi wager $80 thousand in ahead of time money on Pivot Therapeutics' losma...
.Cancer company Oncternal Therapeutics is actually folding all its own clinical tests as well as lay...